Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Change in Acquisitions & Divestments: 2022-2025

Historic Change in Acquisitions & Divestments for Caribou Biosciences (CRBU) over the last 4 years, with Sep 2025 value amounting to $68.4 million.

  • Caribou Biosciences' Change in Acquisitions & Divestments fell 43.30% to $68.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.0 million, marking a year-over-year decrease of 30.89%. This contributed to the annual value of $397.5 million for FY2024, which is 17.54% up from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Change in Acquisitions & Divestments is $68.4 million, which was up 20.72% from $56.7 million recorded in Q2 2025.
  • Caribou Biosciences' 5-year Change in Acquisitions & Divestments high stood at $120.7 million for Q3 2024, and its period low was $39.3 million during Q1 2022.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $72.4 million (2023), whereas its average is $84.2 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first soared by 151.06% in 2023, then plummeted by 47.43% in 2025.
  • Caribou Biosciences' Change in Acquisitions & Divestments (Quarterly) stood at $89.7 million in 2022, then plummeted by 38.72% to $55.0 million in 2023, then spiked by 30.81% to $71.9 million in 2024, then crashed by 43.30% to $68.4 million in 2025.
  • Its last three reported values are $68.4 million in Q3 2025, $56.7 million for Q2 2025, and $66.0 million during Q1 2025.